IP Library › Granted Patent US 9,050,477
Granted Patent B2
US 9,050,477 · App. 13/264,547 · Granted Jun 9, 2015

Cosmetic compositions comprising oridonin and new cosmetic uses

Inventors: Arnaud Fournial (Paris, FR); Philippe Mondon (Paris, FR)
Assignee: SEDERMA
A61Q19/08A61K8/347A61K8/498A61Q19/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,477
App. No.
13/264,547
Granted
Jun 9, 2015
Kind
B2
Abstract

The present invention related to cosmetic compositions comprising oridonin and new cosmetic uses. Oridonin is used for fighting the signs of cutaneous aging and for slimming. A composition comprising a combination of oridonin and darutigenol or a derivative thereof, in particular darutoside, is disclosed together with the cosmetic use of such composition.

Claims (28)

1. A cosmetic composition comprising an effective amount of oridonin and darutoside and a physiological medium.

2. The composition according to claim 1 wherein the amount of oridonin ranges from 0.00001% to 50% by weight of the composition.

3. The composition according to claim 1 wherein the amount of darutoside ranges from 0.00001% to 80% by weight of the composition.

4. The composition according to claim 1 wherein the ratio of oridonin to darutoside ranges from 1:1000 to 10:1.

5. The composition according to claim 1 wherein the oridonin is extracted from Rhabdosia rubescens.

6. The composition according to claim 1 wherein the darutoside is extracted from Siegesbeckia orientalis.

7. A method of improving the general condition of skin comprising topically applying an effective amount of the composition of claim 1 to a subject in need thereof.

8. A method of treating signs of cutaneous aging comprising topically applying an effective amount of the composition of claim 1 to a subject in need thereof.

9. The method of claim 8 wherein said treating signs of cutaneous aging includes treating wrinkles, fine lines, visible and/or tactile skin discontinuities; loss of firmness, elasticity and tone of cutaneous tissue.

10. The method of claim 8 wherein said treating signs of cutaneous aging includes treating oxidative stress and free radicals.

11. The method of claim 8 wherein said treating signs of cutaneous aging includes treating deterioration of chromophore distribution by rebalancing the distribution of haemoglobin and collagen.

12. The method of claim 8 wherein said treating signs of cutaneous aging includes treating melanin spots.

13. The method of claim 8 wherein said treating signs of cutaneous aging includes reducing cutaneous redness.

14. The composition according to claim 1 wherein the amount of oridonin ranges from 0.0001% to 10% by weight of the composition.

15. The composition according to claim 1 wherein the amount of oridonin ranges from 0.001% to 3% by weight of the composition.

16. The composition according to claim 1 wherein the amount of darutoside ranges from 0.001% to 50% by weight of the composition.

17. The composition according to claim 1 wherein the amount of darutoside ranges from 0.01% to 3% by weight of the composition.

18. The composition according to claim 1 wherein the ratio of oridonin to darutoside ranges from 1:1000 to 1:1.

19. The composition according to claim 1 wherein the ratio of oridonin to darutoside ranges from 1:100 to 1.

20. The composition according to claim 1 further comprising at least one agent selected from the group consisting of centella asiatica , asiaticoside and asiatic acid, cafein, thein, theobromin, forskolin, esculin, esculoside, ACE inhibitors, Val-Trp, Neuropeptide Y inhibitors, enkephaline, gingko biloba , yam, dioscorea extract, rutin, yerba mate extract, guarana extract, oligosaccharides, exopolysaccharides, alcohol, carnitin, Ivy extract, focus extract, algae extract, Peumus boldus extract, palmitoylcarnitine, carnosine, taurine, cyclic AMP, and elderberry extract.

21. The composition according to claim 1 further comprising at least one additional active agent selected from the group consisting of anti-aging, whitening, moisturizing, slimming, revitalizing, anti-acne, anti-inflammatory and anti-hair loss agents.

22. The composition according to claim 21 wherein said anti-aging agent contains a thermus thermophiles ferment.

23. The composition according to claim 21 wherein said revitalizing agent contains mineral salts extracted from marine sediments and oyster shells.

24. The composition according to claim 1 further comprising one or more ingredients selected from the group consisting of cleaning agents, hair conditioning agents, skin conditioning agents, hair styling agents, antidandruff agents, hair growth promoters, perfumes, sunscreen compounds, sunblock compounds, pigments, moisturizers, film formers, hair colors, make-up agents, detergents, pharmaceuticals, thickening agents, emulsifiers, humectants, emollients, antiseptic agents, deodorant actives, surfactants and propellants.

25. The composition according to claim 1 wherein said composition is in the form of a solution, dispersion, emulsion, paste, or powder, individually or as a premix, or in vehicles individually or as a premix in vectors such as macro-, micro-, or nanocapsules, macro-, micro- or, nanospheres, liposomes, oleosomes or chylomicrons, macro-, micro-, or nanoparticles or macro-, micro or nanosponges, micro or nano emulsions, or adsorbed on organic polymer powders, talcs, bentonites, or other inorganic or organic supports.

26. The composition of claim 1 further comprising at least one compound capable of stimulating extracellular matrix.

27. The composition of claim 26 wherein said compound is selected from the group consisting of vitamin A, retinoic retinoid acid, retinol, retinoic acid, retinyl proprionate retinol palmitate, vitamin B3, niacinamide, nicotinate tocopherol, vitamin B5, vitamin B6, vitamin B12, vitamin C, ascorbic acid, ascorbyl acid, ascorbyl glucoside, ascorbyl tetrapalmitate, magnesium, sodium ascorbyl phosphate, vitamins E, F, H, K, PP, amino acids, arginine, ornithine, hydroxyproline, hydroxyproline dipalmitate, palmitoylglycine, peptides, copper peptides, Carnosine, allantoine, farnesol, biotine, adenosine, lactic acid, glycolic acid, glucosamine, acetylglucosamine, madecassic acid, asiaticoside and asiatic acids, ellagic acid, salicylic acid, stigmasterol, sitosterol, campesterol, brassicasterol, teprenone, genistein, equol, hexamidine, panthenol, dimethylaminoethanol (DMAE), oils containing DHA/EPA, shea butter, and glycerin.

28. The composition of claim 27 wherein the peptide is selected from the group consisting of the peptide of SEQ ID NO:1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, and SEQ ID NO:5.

Assignments (2)
CORRECTIONS TO REEL/FRAME 027096/0666 TO COUNTRY CODE AND POSTAL CODE FOR SEDERMA Recorded Apr 2, 2013
From: FOURNIAL, ARNAUD; MONDON, PHILIPPE
To: SEDERMA
Reel/Frame 030138/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2011
From: FOURNIAL, ARNAUD; MONDON, PHILIPPE
To: SEDERMA
Reel/Frame 027096/0656 →
Priority Claims (1)
FR 09 01889 · Apr 17, 2009 · national
Continuity (1)
Related Publication 20120028916A1 · Feb 2, 2012